{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 1.56, "width": 1706, "height": 2195, "unit": "pixel", "lines": [{"boundingBox": [280, 406, 1272, 435, 1271, 467, 279, 438], "text": "Gabapentin remained well tolerated after the 4-month, open-label, extension phase;", "words": [{"boundingBox": [280, 407, 414, 411, 414, 443, 280, 439], "text": "Gabapentin"}, {"boundingBox": [420, 411, 533, 414, 533, 446, 420, 443], "text": "remained"}, {"boundingBox": [539, 414, 593, 416, 593, 448, 539, 446], "text": "well"}, {"boundingBox": [599, 416, 704, 419, 704, 451, 599, 448], "text": "tolerated"}, {"boundingBox": [711, 419, 764, 421, 764, 453, 710, 451], "text": "after"}, {"boundingBox": [770, 421, 809, 422, 809, 454, 770, 453], "text": "the"}, {"boundingBox": [816, 422, 925, 425, 925, 457, 816, 454], "text": "4-month,"}, {"boundingBox": [931, 425, 1067, 429, 1067, 461, 931, 457], "text": "open-label,"}, {"boundingBox": [1073, 430, 1185, 433, 1184, 464, 1073, 461], "text": "extension"}, {"boundingBox": [1191, 433, 1271, 436, 1271, 466, 1191, 464], "text": "phase;"}]}, {"boundingBox": [278, 473, 1282, 498, 1281, 534, 277, 509], "text": "24.3% of patients experienced adverse events that the investigators considered to be", "words": [{"boundingBox": [278, 473, 353, 477, 353, 511, 278, 509], "text": "24.3%"}, {"boundingBox": [360, 477, 383, 478, 383, 512, 360, 511], "text": "of"}, {"boundingBox": [390, 478, 484, 482, 484, 515, 390, 512], "text": "patients"}, {"boundingBox": [491, 482, 637, 487, 637, 519, 491, 515], "text": "experienced"}, {"boundingBox": [644, 488, 733, 490, 733, 521, 644, 519], "text": "adverse"}, {"boundingBox": [740, 490, 816, 492, 815, 523, 740, 521], "text": "events"}, {"boundingBox": [823, 493, 867, 494, 867, 524, 822, 523], "text": "that"}, {"boundingBox": [874, 494, 912, 495, 911, 525, 874, 524], "text": "the"}, {"boundingBox": [919, 495, 1074, 498, 1073, 529, 918, 525], "text": "investigators"}, {"boundingBox": [1081, 498, 1208, 499, 1207, 532, 1080, 529], "text": "considered"}, {"boundingBox": [1215, 499, 1239, 500, 1238, 532, 1214, 532], "text": "to"}, {"boundingBox": [1246, 500, 1281, 500, 1280, 533, 1245, 532], "text": "be"}]}, {"boundingBox": [270, 545, 1229, 572, 1228, 603, 269, 576], "text": "associated with the medication. Asthenia, dizziness, and somnolence were most", "words": [{"boundingBox": [274, 547, 397, 550, 397, 580, 274, 576], "text": "associated"}, {"boundingBox": [403, 550, 456, 552, 456, 582, 403, 580], "text": "with"}, {"boundingBox": [462, 552, 502, 553, 501, 583, 461, 582], "text": "the"}, {"boundingBox": [507, 553, 651, 557, 651, 588, 507, 583], "text": "medication."}, {"boundingBox": [657, 557, 773, 560, 772, 591, 656, 588], "text": "Asthenia,"}, {"boundingBox": [778, 560, 892, 564, 891, 594, 778, 591], "text": "dizziness,"}, {"boundingBox": [898, 564, 943, 565, 943, 595, 897, 594], "text": "and"}, {"boundingBox": [949, 565, 1095, 569, 1094, 599, 948, 596], "text": "somnolence"}, {"boundingBox": [1100, 570, 1157, 571, 1157, 600, 1100, 599], "text": "were"}, {"boundingBox": [1163, 571, 1229, 573, 1229, 602, 1162, 601], "text": "most"}]}, {"boundingBox": [269, 615, 1229, 639, 1228, 672, 268, 647], "text": "frequently reported. There were no clinically relevant differences in any clinical", "words": [{"boundingBox": [273, 615, 391, 618, 391, 651, 273, 649], "text": "frequently"}, {"boundingBox": [398, 619, 511, 622, 511, 654, 398, 651], "text": "reported."}, {"boundingBox": [518, 622, 585, 624, 585, 656, 518, 654], "text": "There"}, {"boundingBox": [591, 624, 649, 626, 649, 657, 591, 656], "text": "were"}, {"boundingBox": [656, 626, 687, 627, 687, 658, 656, 657], "text": "no"}, {"boundingBox": [694, 627, 803, 630, 803, 661, 694, 658], "text": "clinically"}, {"boundingBox": [810, 630, 908, 632, 908, 664, 810, 661], "text": "relevant"}, {"boundingBox": [914, 633, 1046, 636, 1046, 668, 914, 664], "text": "differences"}, {"boundingBox": [1052, 636, 1079, 637, 1079, 669, 1052, 668], "text": "in"}, {"boundingBox": [1086, 637, 1128, 638, 1128, 670, 1086, 669], "text": "any"}, {"boundingBox": [1135, 638, 1228, 640, 1228, 673, 1135, 670], "text": "clinical"}]}, {"boundingBox": [269, 683, 1170, 708, 1169, 742, 268, 718], "text": "laboratory measurements for any gabapentin group compared with placebo.", "words": [{"boundingBox": [270, 685, 392, 689, 391, 719, 269, 714], "text": "laboratory"}, {"boundingBox": [398, 689, 573, 694, 572, 726, 397, 720], "text": "measurements"}, {"boundingBox": [579, 694, 614, 695, 613, 727, 578, 726], "text": "for"}, {"boundingBox": [620, 696, 665, 697, 663, 729, 619, 728], "text": "any"}, {"boundingBox": [670, 697, 803, 700, 801, 733, 669, 729], "text": "gabapentin"}, {"boundingBox": [809, 701, 877, 702, 875, 734, 807, 733], "text": "group"}, {"boundingBox": [883, 702, 1003, 705, 1001, 737, 881, 734], "text": "compared"}, {"boundingBox": [1009, 705, 1064, 706, 1061, 738, 1007, 737], "text": "with"}, {"boundingBox": [1069, 706, 1171, 708, 1168, 739, 1067, 738], "text": "placebo."}]}, {"boundingBox": [816, 775, 863, 775, 862, 794, 815, 794], "text": ".. ..", "words": [{"boundingBox": [822, 775, 835, 775, 835, 794, 822, 794], "text": ".."}, {"boundingBox": [839, 775, 856, 775, 856, 794, 839, 794], "text": "..", "confidence": "Low"}]}, {"boundingBox": [1573, 1054, 1609, 1059, 1607, 1072, 1571, 1068], "text": ". . .", "words": [{"boundingBox": [1575, 1053, 1581, 1054, 1579, 1068, 1574, 1067], "text": "."}, {"boundingBox": [1584, 1054, 1591, 1055, 1589, 1069, 1582, 1068], "text": "."}, {"boundingBox": [1594, 1056, 1603, 1057, 1601, 1071, 1592, 1069], "text": "."}]}, {"boundingBox": [1031, 1736, 1092, 1739, 1091, 1754, 1030, 1751], "text": ". . .: .", "words": [{"boundingBox": [1033, 1737, 1042, 1738, 1039, 1751, 1031, 1751], "text": ".", "confidence": "Low"}, {"boundingBox": [1052, 1738, 1061, 1739, 1059, 1752, 1050, 1752], "text": "."}, {"boundingBox": [1064, 1739, 1074, 1740, 1072, 1753, 1062, 1752], "text": ".:"}, {"boundingBox": [1077, 1740, 1086, 1740, 1084, 1753, 1075, 1753], "text": "."}]}, {"boundingBox": [1163, 1738, 1190, 1748, 1186, 1761, 1159, 1750], "text": ".", "words": [{"boundingBox": [1176, 1741, 1185, 1745, 1180, 1758, 1171, 1754], "text": ".", "confidence": "Low"}]}, {"boundingBox": [943, 1803, 995, 1807, 993, 1822, 941, 1818], "text": ". . .", "words": [{"boundingBox": [944, 1804, 953, 1805, 951, 1819, 942, 1818], "text": "."}, {"boundingBox": [960, 1805, 969, 1806, 968, 1820, 959, 1819], "text": "."}, {"boundingBox": [976, 1807, 986, 1807, 984, 1821, 975, 1820], "text": "."}]}, {"boundingBox": [576, 1964, 583, 1820, 604, 1821, 598, 1965], "text": ": .... . . . .", "words": [{"boundingBox": [578, 1955, 579, 1941, 600, 1942, 599, 1956], "text": ":", "confidence": "Low"}, {"boundingBox": [579, 1931, 581, 1900, 601, 1901, 600, 1932], "text": "....", "confidence": "Low"}, {"boundingBox": [582, 1894, 582, 1885, 602, 1886, 601, 1896], "text": "."}, {"boundingBox": [582, 1880, 583, 1866, 602, 1867, 602, 1881], "text": ".", "confidence": "Low"}, {"boundingBox": [583, 1855, 584, 1841, 603, 1842, 602, 1856], "text": ".", "confidence": "Low"}, {"boundingBox": [584, 1836, 585, 1822, 603, 1822, 603, 1836], "text": ".", "confidence": "Low"}]}, {"boundingBox": [1270, 2045, 1303, 2043, 1302, 2073, 1270, 2075], "text": "17", "words": [{"boundingBox": [1269, 2044, 1300, 2043, 1302, 2072, 1271, 2073], "text": "17"}]}, {"boundingBox": [24, 2156, 220, 2154, 221, 2184, 25, 2185], "text": "CONFIDENTIAL", "words": [{"boundingBox": [27, 2158, 216, 2155, 218, 2185, 28, 2185], "text": "CONFIDENTIAL"}]}, {"boundingBox": [375, 2147, 1555, 2155, 1554, 2195, 375, 2189], "text": "Source: https://www.industrydocuments.ucsf.edu/docs/fmjmprizer LeslieTive 0020906", "words": [{"boundingBox": [378, 2154, 490, 2152, 490, 2189, 377, 2189], "text": "Source:"}, {"boundingBox": [497, 2152, 1329, 2159, 1330, 2192, 497, 2189], "text": "https://www.industrydocuments.ucsf.edu/docs/fmjmprizer", "confidence": "Low"}, {"boundingBox": [1336, 2159, 1455, 2163, 1456, 2192, 1337, 2192], "text": "LeslieTive"}, {"boundingBox": [1462, 2163, 1553, 2167, 1555, 2193, 1463, 2192], "text": "0020906"}]}]}]}